Patents by Inventor Francesco Berlanda Scorza

Francesco Berlanda Scorza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11339367
    Abstract: Hyperblebbing Shigella strains are generated by disrupting one or more components of the Tol-Pal system. The blebs from these strains are useful immunogens for vaccination. The individual proteins found in these blebs can also be used as immunogens.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: May 24, 2022
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Christiane Gerke, Francesco Berlanda Scorza, Allan Saul, Luana Maggiore
  • Patent number: 11155572
    Abstract: Methods for purifying RNA from a sample, comprising one or more steps of tangential flow filtration, hydroxyapatite chromatography, core bead flow-through chromatography, or any combinations thereof. These techniques are useful individually, but show very high efficiency when used in combination, or when performed in particular orders. The methods can purify RNA in a highly efficient manner without unduly compromising potency or stability, to provide compositions in which RNA is substantially cleared of contaminants. Moreover, they can be performed without the need for organic solvents.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: October 26, 2021
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Francesco Berlanda Scorza, Yingxia Wen, Andrew Geall, Frederick Porter
  • Publication number: 20210214388
    Abstract: Methods for purifying RNA from a sample, comprising one or more steps of tangential flow filtration, hydroxyapatite chromatography, core bead flow-through chromatography, or any combinations thereof. These techniques are useful individually, but show very high efficiency when used in combination, or when performed in particular orders. The methods can purify RNA in a highly efficient manner without unduly compromising potency or stability, to provide compositions in which RNA is substantially cleared of contaminants. Moreover, they can be performed without the need for organic solvents.
    Type: Application
    Filed: January 25, 2021
    Publication date: July 15, 2021
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Francesco BERLANDA SCORZA, Yingxia WEN, Andrew GEALL, Frederick PORTER
  • Publication number: 20180298064
    Abstract: Disclosed herein are various open reading frames from a strain of E. coli responsible for neonatal meningitis (MNEC), and a subset of these that is of particular interest for preparing compositions for immunising against MNEC infections.
    Type: Application
    Filed: June 26, 2018
    Publication date: October 18, 2018
    Applicants: GlaxoSmithKline Biologicals SA, J. Craig Venter Institute, Inc.
    Inventors: Vega MASIGNANI, Danilo Gomes MORIEL, Francesco BERLANDA SCORZA, Nathalie NORAIS, Maria Rita FONTANA, Mariagrazia PIZZA, Laura SERINO, Hervé TETTELIN
  • Patent number: 10035826
    Abstract: Disclosed herein are various open reading frames from a strain of E. coli responsible for neonatal meningitis (MNEC), and a subset of these that is of particular interest for preparing compositions for immunizing against MNEC infections.
    Type: Grant
    Filed: May 9, 2016
    Date of Patent: July 31, 2018
    Assignees: GlaxoSmithKline Biologicals SA, J. Craig Venture Institute, Inc.
    Inventors: Vega Masignani, Danilo Gomes Moriel, Francesco Berlanda Scorza, Nathalie Norais, Maria Rita Fontana, Mariagrazia Pizza, Laura Serino, Herve Tettelin
  • Publication number: 20160289632
    Abstract: Hyperblebbing Shigella strains are generated by disrupting one or more components of the Tol-Pal system. The blebs from these strains are useful immunogens for vaccination. The individual proteins found in these blebs can also be used as immunogens.
    Type: Application
    Filed: April 8, 2016
    Publication date: October 6, 2016
    Inventors: Christiane Gerke, Francesco Berlanda Scorza, Allan Saul, Luana Maggiore
  • Publication number: 20160244489
    Abstract: Disclosed herein are various open reading frames from a strain of E. coli responsible for neonatal meningitis (MNEC), and a subset of these that is of particular interest for preparing compositions for immunising against MNEC infections.
    Type: Application
    Filed: May 9, 2016
    Publication date: August 25, 2016
    Applicants: GlaxoSmithKline Biologicals SA, J. Craig Venter Institute, Inc.
    Inventors: Vega MASIGNANI, Danilo Gomes MORIEL, Francesco BERLANDA SCORZA, Nathalie NORAIS, Maria Rita FONTANA, Mariagrazia PIZZA, Laura SERINO, Herve TETTELIN
  • Patent number: 9334313
    Abstract: Disclosed herein are various open reading frames from a strain of E. coli responsible for neonatal meningitis (MNEC), and a subset of these that is of particular interest for preparing compositions for immunizing against MNEC infections.
    Type: Grant
    Filed: June 2, 2014
    Date of Patent: May 10, 2016
    Assignee: GlaxoSmithKline Biologicals SA
    Inventors: Vega Masignani, Danilo Gomes Moriel, Francesco Berlanda Scorza, Nathalie Norais, Maria Rita Fontana, Mariagrazia Pizza, Laura Serino, Herve Tettelin
  • Publication number: 20160024139
    Abstract: Methods for purifying RNA from a sample, comprising one or more steps of tangential flow filtration, hydroxyapatite chromatography, core bead flow-through chromatography, or any combinations thereof. These techniques are useful individually, but show very high efficiency when used in combination, or when performed in particular orders. The methods can purify RNA in a highly efficient manner without unduly compromising potency or stability, to provide compositions in which RNA is substantially cleared of contaminants. Moreover, they can be performed without the need for organic solvents.
    Type: Application
    Filed: March 13, 2014
    Publication date: January 28, 2016
    Inventors: Francesco BERLANDA SCORZA, Yingxia WEN, Andrew GEALL, Frederick PORTER
  • Publication number: 20140356389
    Abstract: Disclosed herein are various open reading frames from a strain of E. coli responsible for neonatal meningitis (MNEC), and a subset of these that is of particular interest for preparing compositions for immunising against MNEC infections.
    Type: Application
    Filed: June 2, 2014
    Publication date: December 4, 2014
    Applicants: J. CRAIG VENTER INSTITUTE, INC., NOVARTIS VACCINES AND DIAGNOSTICS SRL
    Inventors: Vega MASIGNANI, Danilo Gomes MORIEL, Francesco BERLANDA SCORZA, Nathalie NORAIS, Maria Rita FONTANA, Mariagrazia PIZZA, Laura SERINO, Herve TETTELIN
  • Patent number: 8758764
    Abstract: Disclosed herein are various open reading frames from a strain of E. coli responsible for neonatal meningitis (MNEC), and a subset of these that is of particular interest for preparing compositions for immunising against MNEC infections.
    Type: Grant
    Filed: February 17, 2006
    Date of Patent: June 24, 2014
    Assignees: Novartis Vaccines and Diagnostics Srl, J. Craig Venter Institute
    Inventors: Vega Masignani, Danilo Gomes Moriel, Francesco Berlanda Scorza, Nathalie Norais, Maria Rita Fontana, Mariagrazia Pizza, Laura Serino, Herve Tettelin
  • Publication number: 20130052227
    Abstract: Hyperblebbing Shigella strains are generated by disrupting one or more components of the Tol-Pal system. The blebs from these strains are useful immunogens for vaccination. The individual proteins found in these blebs can also be used as immunogens.
    Type: Application
    Filed: September 28, 2010
    Publication date: February 28, 2013
    Applicant: Novartis Vaccines Institute For Global Health S.R.L.
    Inventors: Christiane Gerke, Francesco Berlanda Scorza, Allan Saul, Luana Maggiore
  • Publication number: 20130004531
    Abstract: Disclosed herein are various polypeptides that can be included in immunogenic compositions specific for pathogenic E. coli strains. The polypeptides have cellular locations which render them accessible to the immune system. The genes encoding the polypeptides were initially identified as being present in uropathogenic strain 536 but absent from non-pathogenic strains.
    Type: Application
    Filed: September 4, 2012
    Publication date: January 3, 2013
    Applicants: Robert Koch Institute, Novartis Vaccines and Diagnostics SRL
    Inventors: Francesco BERLANDA SCORZA, Maria Rita Fontana, Danilo Gomes Moriel, Mariagrazia Pizza, Laura Serino, Jörg Hacker
  • Publication number: 20120058146
    Abstract: Disclosed herein are various genes that can be included in immunogenic compositions specific for pathogenic E. coli strains. The genes are from uropathogenic strains but are absent from non-pathogenic strains, and their encoded proteins have cellular locations which render them accessible to the immune system.
    Type: Application
    Filed: November 9, 2011
    Publication date: March 8, 2012
    Applicant: Novartis Vaccines and Diagnostics SRL
    Inventors: Danilo Gomes Moriel, Francesco Berlanda Scorza, Mariagrazia PIZZA, Laura Serino, Maria Rita Fontana
  • Patent number: 8062644
    Abstract: Disclosed herein are various genes that can be included in immunogenic compositions specific for pathogenic E. coli strains. The genes are from uropathogenic strains but are absent from non-pathogenic strains, and their encoded proteins have cellular locations which render them accessible to the immune system.
    Type: Grant
    Filed: February 17, 2006
    Date of Patent: November 22, 2011
    Assignee: Novartis Vaccines & Diagnostics SRL.
    Inventors: Mariagrazia Pizza, Laura Serino, Francesco Berlanda Scorza, Danilo Gomes Moriel, Maria Rita Fontana
  • Publication number: 20100166788
    Abstract: Disclosed herein are various polypeptides that can be included in immunogenic compositions specific for pathogenic E. coli strains. The polypeptides have cellular locations which render them accessible to the immune system. The genes encoding the polypeptides were initially identified as being present in uropathogenic strain 536 but absent from non-pathogenic strains.
    Type: Application
    Filed: August 15, 2007
    Publication date: July 1, 2010
    Applicant: NOVARTIS VACCINES AND DIAGNOSTICS
    Inventors: Francesco Berlanda Scorza, Danilo Gomes Moriel, Jörg Hacker, Mariagrazia Pizza, Laura Serino, Maria Rita Fontana
  • Publication number: 20090324633
    Abstract: Disclosed herein are various genes that can be included in immunogenic compositions specific for pathogenic E. coli strains. The genes are from uropathogenic strains but are absent from non-pathogenic strains, and their encoded proteins have cellular locations which render them accessible to the immune system.
    Type: Application
    Filed: February 17, 2006
    Publication date: December 31, 2009
    Applicant: Novartis Vaccines and Diagnostics, S.R.L.
    Inventors: Maria-grazia Pizza, Laura Serino, Francesco Berlanda Scorza, Danilo Gomes Moriel, Maria Rita Fontana